NVAX insider transactions
Novavax Inc. (NVAX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for NVAX
- Director Newton Charles W. converted options into 9,520 shares (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by Walker Robert Edward4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 3 filed by new insider Walker Robert Edward3 - NOVAVAX INC (0001000694) (Issuer)
- Director Shiver John W. converted options into 7,947 shares (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, CFO and Treasurer Kelly James Patrick converted options into 12,223 shares and covered exercise/tax liability with 5,904 shares, increasing direct ownership by 5% to 130,599 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Amendment: SEC Form 4 filed by EVP, CFO and Treasurer Kelly James Patrick4/A - NOVAVAX INC (0001000694) (Issuer)
- Amendment: SEC Form 4 filed by EVP, Research & Development Draghia-Akli Ruxandra4/A - NOVAVAX INC (0001000694) (Issuer)
- Amendment: SEC Form 4 filed by EVP, Chief Legal Officer Casey Mark J4/A - NOVAVAX INC (0001000694) (Issuer)
- Amendment: SEC Form 4 filed by President and CEO Jacobs John C4/A - NOVAVAX INC (0001000694) (Issuer)
- Amendment: SEC Form 4 filed by EVP, Chief Strategy Officer O'Hara Elaine4/A - NOVAVAX INC (0001000694) (Issuer)
- President and CEO Jacobs John C converted options into 150,167 shares and covered exercise/tax liability with 69,288 shares, increasing direct ownership by 98% to 225,680 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, CFO and Treasurer Kelly James Patrick converted options into 43,167 shares and covered exercise/tax liability with 20,850 shares, increasing direct ownership by 22% to 124,280 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, Chief Strategy Officer O'Hara Elaine converted options into 56,334 shares and covered exercise/tax liability with 22,429 shares, increasing direct ownership by 34% to 134,642 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, Chief Legal Officer Casey Mark J converted options into 37,500 shares and covered exercise/tax liability with 11,378 shares, increasing direct ownership by 41% to 90,067 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, Research & Development Draghia-Akli Ruxandra converted options into 26,667 shares and covered exercise/tax liability with 11,313 shares, increasing direct ownership by 187% to 23,563 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- President and CEO Jacobs John C converted options into 83,333 shares and covered exercise/tax liability with 38,450 shares, increasing direct ownership by 25% to 225,680 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, CFO and Treasurer Kelly James Patrick converted options into 58,666 shares and covered exercise/tax liability with 28,366 shares, increasing direct ownership by 42% to 101,963 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, Chief Strategy Officer O'Hara Elaine covered exercise/tax liability with 16,344 shares and converted options into 59,600 shares, increasing direct ownership by 75% to 100,737 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, Chief Legal Officer Casey Mark J converted options into 4,000 shares and covered exercise/tax liability with 1,214 shares, increasing direct ownership by 5% to 63,945 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- President and CEO Jacobs John C covered exercise/tax liability with 39,132 shares and converted options into 83,197 shares, increasing direct ownership by 32% to 180,797 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, Chief Legal Officer Casey Mark J converted options into 41,899 shares and covered exercise/tax liability with 12,713 shares, increasing direct ownership by 91% to 61,159 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Section 16 Draghia-Akli Ruxandra converted options into 14,257 shares and covered exercise/tax liability with 6,048 shares (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Director Rodgers Richard J converted options into 3,800 shares, increasing direct ownership by 15% to 28,490 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by Director Rodgers Richard J4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by Director Mott David M4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by Director King Rachel K.4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by Director Douglas Richard4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by Director Alton Gregg H4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by Director Mcglynn Margaret G4 - NOVAVAX INC (0001000694) (Issuer)
- Director Mcglynn Margaret G converted options into 10,420 shares, increasing direct ownership by 69% to 25,588 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Director Alton Gregg H converted options into 10,420 shares, increasing direct ownership by 57% to 28,805 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Director King Rachel K. converted options into 10,420 shares, increasing direct ownership by 71% to 25,190 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Director Rodgers Richard J converted options into 10,420 shares, increasing direct ownership by 73% to 24,690 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Director Mott David M converted options into 10,420 shares, increasing direct ownership by 21% to 60,890 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Director Douglas Richard converted options into 10,420 shares, increasing direct ownership by 24% to 54,340 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by Director Newton Charles W.4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 3 filed by new insider Newton Charles W.3 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by Director Shiver John W.4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 3 filed by new insider Shiver John W.3 - NOVAVAX INC (0001000694) (Issuer)
- President and COO Trizzino John converted options into 28,890 shares and covered exercise/tax liability with 13,954 shares, increasing direct ownership by 28% to 68,061 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, CFO and Treasurer Kelly James Patrick converted options into 12,223 shares and covered exercise/tax liability with 5,904 shares, increasing direct ownership by 10% to 69,251 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by EVP, Chief Legal Officer Casey Mark J4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by Section 16 Draghia-Akli Ruxandra4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by President and CEO Jacobs John C4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by EVP, Chief Strategy Officer O'Hara Elaine4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by EVP, CFO and Treasurer Kelly James Patrick4 - NOVAVAX INC (0001000694) (Issuer)
- President and COO Trizzino John converted options into 48,000 shares and covered exercise/tax liability with 23,185 shares, increasing direct ownership by 88% to 53,125 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, Chief Legal Officer Casey Mark J converted options into 4,000 shares and covered exercise/tax liability with 1,214 shares, increasing direct ownership by 10% to 31,973 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, CFO and Treasurer Kelly James Patrick converted options into 58,667 shares and covered exercise/tax liability with 28,337 shares, increasing direct ownership by 93% to 62,932 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- President and CEO Jacobs John C converted options into 83,334 shares and covered exercise/tax liability with 38,451 shares, increasing direct ownership by 49% to 136,732 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, Chief Strategy Officer O'Hara Elaine converted options into 59,600 shares and covered exercise/tax liability with 16,344 shares, increasing direct ownership by 304% to 57,481 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Director Alton Gregg H was granted 7,915 shares, increasing direct ownership by 384% to 18,385 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Director Mcglynn Margaret G was granted 4,698 shares, increasing direct ownership by 299% to 15,168 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- President and CEO Jacobs John C converted options into 83,196 shares and covered exercise/tax liability with 38,873 shares, increasing direct ownership by 93% to 91,849 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, CFO and Treasurer Kelly James Patrick covered exercise/tax liability with 16,906 shares and converted options into 35,000 shares, increasing direct ownership by 125% to 32,602 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Director Rodgers Richard J converted options into 3,800 shares, increasing direct ownership by 36% to 14,270 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Director King Rachel K. sold $37,435 worth of shares (4,150 units at $9.02), decreasing direct ownership by 22% to 14,770 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- Director Young James F sold $82,208 worth of shares (10,000 units at $8.22), decreasing direct ownership by 16% to 51,760 units (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- EVP, Chief Legal Officer Casey Mark J converted options into 41,900 shares and covered exercise/tax liability with 12,713 shares (SEC Form 4)4 - NOVAVAX INC (0001000694) (Issuer)
- SEC Form 4 filed by Section 16 Draghia-Akli Ruxandra4 - NOVAVAX INC (0001000694) (Issuer)